TCBPYTC BioPharm (Holdings) plc

About TC BioPharm (Holdings) plc (TCBPY)

TC BioPharm (Holdings) plc (TCBPY) is a Biotechnology company headquartered in Motherwell, SCL, United Kingdom whose shares trade over-the-counter on the Pink tier.

Clinical stage biopharmaceutical company engaged in the development of immunotherapy products based on a proprietary allogeneic gamma delta T cell platform

TCBPY key facts

Ticker symbol

TCBPY

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Motherwell, SCL, United Kingdom

Country of incorporation

GB

Year of incorporation

2020

Employees

40

Estimated market cap

$431.1K (as of Apr 9, 2025)

Shares outstanding

8,412,215,651

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

TC BioPharm (Holdings) plc leadership

• Bryan Kobel — CEO
• Martin Thorp — CFO
• Toby Rintoul — EVP, Fin.
• Christopher Camarra — EVP

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with T